FDA Inspection 1324390 — Jeffrey J. Sperinde, PhD
The FDA completed an inspection of Jeffrey J. Sperinde, PhD on Jun 30, 2026 in South San Francisco, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 30, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- South San Francisco, CA (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7013 | 21 CFR 812.110(d) | Inadequate financial disclosure by investigator |
| 7231 | 21 CFR 50.20 | Consent not obtained, exceptions do not apply |